Peripheral nerve stimulation (PNS) is a drug-free pain management procedure that uses electrical impulses to target specific nerves and block pain signals. PNS helps decrease perception of pain, providing real answers to patients dealing with chronic knee pain. The case study discussed in this presentation is of the use of PNS targeting the superior lateral genicular nerve and the saphenous nerve for a patient with moderate to severe knee pain from osteoarthritis

Inclusion Criteria:

1. adults between the ages of 30 and 70 years with a clinical diagnosis of moderate to severe knee OA who suffered knee pain.
2. Patients who cannot afford intra-articular injections or radiofrequency ablation (RFA).
3. patients who had failed 2 different oral pain medications and 6 weeks of physical therapy.

Exclusion Criteria:

1. Patients with OA show improvement in pain after physiotherapy.
2. patients evaluated by an orthopaedic surgeon and deemed to be surgical candidates due to knee pathologies other than OA.
3. pregnant patients.
4. patients on anticoagulation therapy, who were not permitted to stop anticoagulation.
5. patients with previous trauma, neurological or endocrine diseases like diabetes mellitus, and knee tumors; and patients with inflammatory arthritis.
6. people who had received an intra-articular knee injection within the last 6 months.
7. Patients with tendon tears, bursitis, or calcified tendonitis as proven by imaging.

Plan to Share IPD: "Yes" Plan Description: "Data obtained through this study may be provided to qualified researchers with academic interest in scapular dyskinesis. Data or samples shared will be coded, with no PHI included. Approval of the request and execution of all applicable agreements (i.e., a material transfer agreement) are prerequisites to the sharing of data with the requesting party.

Results will be published by the investigators in academic journal.

Data requests can be submitted starting 9 months after article publication and the data will be made accessible for up to 24 months. Extensions will be considered on a case-by-case basis

Access to trial IPD can be requested by qualified researchers engaging in independent scientific research and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA).

This is a prospective, double-blinded, randomised study. The closed envelop randomization method will be used for the randomization of the patients who will be also blinded to group allocation.